Myositis Associated Interstitial Lund Disease (MA-ILD)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Myositis Associated Interstitial Lund Disease (MA-ILD) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 4

NCT05799755

Myositis Interstitial Lung Disease Nintedanib Trial

This research study will evaluate safety and how well the study drug, nintedanib improve symptoms in participants with myositis associated interstitial lung dis…

United States49 participantsStarted 2023-08-01

Treatment: Nintedanib, Placebo